SEC62 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.800200E-01
Normal-vs-Stage2
8.750600E-01
Normal-vs-Stage3
7.462600E-01
Normal-vs-Stage4
3.436200E-01
Stage1-vs-Stage2
6.550600E-01
Stage1-vs-Stage3
5.903200E-01
Stage1-vs-Stage4
2.519000E-01
Stage2-vs-Stage3
8.299200E-01
Stage2-vs-Stage4
3.830000E-02
Stage3-vs-Stage4
1.926640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.470400E-01
Normal-vs-AfricanAmerican
7.302000E-01
Normal-vs-Asian
6.256200E-01
Caucasian-vs-AfricanAmerican
3.247800E-01
Caucasian-vs-Asian
5.101800E-01
AfricanAmerican-vs-Asian
2.894000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.428400E-01
Normal-vs-Female
9.644600E-01
Male-vs-Female
5.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.067600E-01
Normal-vs-Age(41-60Yrs)
8.055000E-01
Normal-vs-Age(61-80Yrs)
7.565400E-01
Normal-vs-Age(81-100Yrs)
5.719800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.072400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.594000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.710400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.670000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.879810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.349600E-01
Normal-vs-Daily Drinker
2.171600E-01
Normal-vs-Weekly Drinker
4.702800E-01
Normal-vs-Occasional Drinker
7.146800E-01
Normal-vs-Social Drinker
8.652400E-01
Non Drinker-vs-Daily Drinker
4.220400E-01
Non Drinker-vs-Weekly Drinker
9.542400E-01
Non Drinker-vs-Occasional Drinker
5.231900E-02
Non Drinker-vs-Social Drinker
1.125190E-01
Daily Drinker-vs-Weekly Drinker
5.142800E-01
Daily Drinker-vs-Occasional Drinker
2.287500E-02
Daily Drinker-vs-Social Drinker
2.957600E-02
Weekly Drinker-vs-Occasional Drinker
1.046010E-01
Weekly Drinker-vs-Social Drinker
1.778390E-01
Occasional Drinker-vs-Social Drinker
6.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.092100E-02
Normal-vs-Grade 2
3.750400E-02
Normal-vs-Grade 3
3.812200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.006400E-01
Grade 1-vs-Grade 3
1.400820E-01
Grade 1-vs-Grade 4
7.092100E-02
Grade 2-vs-Grade 3
4.376400E-01
Grade 2-vs-Grade 4
3.750400E-02
Grade 3-vs-Grade 4
3.812200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.587200E-01
Normal-vs-NonDiabetic
7.569800E-01
Diabetic-vs-NonDiabetic
5.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.944400E-01
Normal-vs-NoPancreatitis
7.892600E-01
Pancreatitis-vs-NoPancreatitis
1.888640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.302400E-01
Normal-vs-N1
9.071000E-01
N0-vs-N1
9.647600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.091000E-01
Normal-vs-TP53-NonMutant
9.723000E-01
TP53-Mutant-vs-TP53-NonMutant
4.355600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
